Forte Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 45 | -17 | -15 | -13 |
EBITDA | -24,552 | -17,665 | -11,564 | -16,111 |
EBIT | -24,571 | -17,682 | -11,579 | -16,124 |
Net Income | -24,788 | -17,682 | -11,249 | -15,656 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,466 | -14,055 | -10,061 | -10,416 |
Cash | 76,957 | 93,414 | 106,144 | 45,856 |
Basic Shares | 147,177 | 17,793 | 11,744 | 11,398 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -64 | -39 | -9 | |
EBITDA | -70,593 | -35,439 | -32,476 | -13,896 |
EBIT | -70,657 | -35,478 | -32,485 | -13,896 |
Net Income | -69,375 | -35,478 | -31,476 | -13,862 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -50,998 | -30,782 | -28,794 | -8,185 |
Cash | 76,957 | 22,244 | 11,961 | 41,100 |
Basic Shares | 147,177 | 2,915 | 1,262 | 695 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.91 |
2025-12-31 | -$1.45 |
2025-09-30 | -$0.99 |
2025-06-30 | -$0.96 |